Consortium Service Management Group Announces Results of Trauma Surgery Using Patented Tissue-Bonding Technology

Story Posted: 07-27-04

CORPUS CHRISTI, Texas, July 27 /PRNewswire-FirstCall/ -- Consortium Service Management Group, Inc. (OTC Bulletin Board: CTUM) (CSMG) announced today the results of traumatologic surgical intrusions performed in Ukraine clinics. The trials were conducted under the auspices of the company's subsidiary, Live Tissue Connect.

The company said seven surgical intrusions had been successfully completed as of July 7, 2004, including procedures treating multiple fractures of pelvic bones. Results from the surgeries included significant reduction of blood loss from 3-3.5 liters to 850 ml and a one and a half times reduction in surgery time.

Donald S. Robbins, CEO of CSMG, said, "The results of the surgeries showed that our versatile tissue-bonding/welding technology has significant advantages in traumatologic operations including considerable reduction of blood loss, operation time reduction and faster healing of postoperative wounds."

Robbins said the procedures successfully completed during the trials included osteosynthesis of femoral bone and osteosynthesis of shin bone. In a case of fracture of the humerus, surgery involved removal of metalwork after a long postoperative time term.

About CSMG's Tissue-Bonding Technology

CSMG's patented tissue-bonding device bonds through radiofrequency fusion and reconnects living soft biological tissue (organs) without the use of foreign matter or conventional wound-closing devices such as sutures, staples, sealant or glues. The technology leaves little or no scar visible to the naked eye after a few months. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the CSMG-patented technology bonds and reconnects incised tissue and avoids charring, searing and necrosis by using a patented low-heat delivery method aimed at restoration of the normal functions of the live organs and tissue. U.S. and Australia patents have been issued, with other U.S. and foreign patents pending.

In Ukraine, nearly 3,000 successful human surgeries in clinical trials have been completed on various organs using a number of types of procedures. Today, surgeons at five Ukraine hospitals and clinics are using the tissue- bonding technology in clinical trials and performing over 100 new surgeries each month for open and laparoscopic surgical procedures and techniques. The procedures so far have involved the bonding and reconnecting of incised or separated human tissues in the following body areas -- nasal septum, intestine, stomach, skin, gall bladder, liver, spleen, blood vessels, nerves, alba linea, uterus, fallopian tube, ovary and testicles and dura-matter -- while restoring the normal function of the body organ or tissue.

CSMG owns the technology and exclusive world rights to the medical device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology. The technology was invented and developed at the internationally renowned E.O. Paton Institute of Electric Welding, National Academy of Sciences of Ukraine at Kiev, Ukraine headed by Professor B.E. Paton.

CSMG maintains offices in Corpus Christi, TX, Oklahoma City, OK and Kiev, Ukraine. The company website is http://www.ctum.com and its email address is publicrelations@ctum.com.  

A profile for investors may be found at the website http://www.hawkassociates.com/csmg/profile.htm  

Additional information about CSMG can be found on the website http://www.ctum.com. An online investor kit containing CSMG press releases, SEC filings, current price Level II quotes, interactive Java, stock charts and other useful information for investors can be found at http://www.hawkassociates.com and http://www.hawkmicrocaps.com. Investors may contact Don Robbins or Gordon Allison, CSMG at (361) 887-7546 or Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 852-2383, email: info@hawkassociates.com.  

© 2004 PRNewswire

 Advertising Information